Featured Research

from universities, journals, and other organizations

Too Many Women Still Dying From Breast Cancer, Says UK Charity

Date:
March 30, 2008
Source:
BioMed Central
Summary:
Thousands of women die from breast cancer each year because current treatments are not always effective and in some cases fail to stem the disease, warns the United Kingdom-based charity Breast Cancer Campaign.

Thousands of women die from breast cancer each year because current treatments are not always effective and in some cases fail to stem the disease, warns the United Kingdom-based charity Breast Cancer Campaign.

In a comprehensive review of breast cancer research published today, 56 of the UK's most influential breast cancer experts have identified the key research gaps and priorities for the greatest potential impact on patients.

Breast cancer treatment has improved over the past few decades and led to increased survival rates and better quality of life, the report highlights. However over 44,000 women in the UK are diagnosed with breast cancer each year and around 12,500 will die.

Unfortunately, not enough is known about why treatments don't work for some patients or why breast cancer can return, sometimes many years later, says Breast Cancer Campaign.

The new study, one of the largest ever carried out in the UK and published by the open access journal Breast Cancer Research, is a unique insight into the current state of breast cancer research and its future challenges.

Gaps in key areas of breast cancer research have been identified in the report, says the charity: prevention, detection, spread or recurrence of the disease, treatment, pathology, physiology, genetics and psychosocial aspects of breast cancer.

Among the recommendations for future research priorities pinpointed by Breast Cancer Campaign:

  • Identify new ways to predict and prevent breast cancer
  • Predict who will develop advanced or secondary disease
  • Determine how and why breast cancer spreads to other parts of the body
  • Devise a suitable method to determine the effectiveness of a treatment at an early stage
  • Understand more about the psychosocial and psychological impacts of breast cancer

Pamela Goldberg, Chief Executive Breast Cancer Campaign said, "Breast cancer research has made considerable progress over the past two decades and vital work is still underway. But there are still significant knowledge gaps.

"Greater attention must be paid to all stages of breast cancer. The experiences of older women and those from minority ethnic groups must be considered, particularly in light of recent research showing breast cancer develops earlier in black women and their survival rates are poorer."

Breast Cancer Campaign is already playing a leading role in filling some of the research gaps identified in the report. The charity is currently spending 11.3 million on over 90 research projects around the UK, looking at all areas from screening and prevention to genetics and treatment.

The development of a computer programme that will quickly tell clinicians which is the best treatment for an individual is just one of the many research projects funded by the charity.

Accurately identifying who will respond, or not respond, to breast cancer treatments is very difficult. The computer programme will be able to predict which patients will benefit most, not only from current treatments, but also any new therapies that may come onto the market, paving the way for treatment tailored to the individual and ultimately saving lives.

"We have set out a blueprint for future breast cancer research by this analysis and we are already filling some of the gaps," says Pamela Goldberg.

"While we are working in an exciting age of discovery, our resources are limited. The Government, funding bodies and scientists should focus on these gaps to drive advances in knowledge into improvements in patient care. If we co-ordinate our resources and target the priorities in breast cancer research, we can ensure an environment of scientific excellence and plug these gaps."

Journal reference: Gaps in breast cancer treatment. Breast Cancer Research 2008, 10:R26 http://breast-cancer-research.com/content/10/2/R26


Story Source:

The above story is based on materials provided by BioMed Central. Note: Materials may be edited for content and length.


Cite This Page:

BioMed Central. "Too Many Women Still Dying From Breast Cancer, Says UK Charity." ScienceDaily. ScienceDaily, 30 March 2008. <www.sciencedaily.com/releases/2008/03/080327172227.htm>.
BioMed Central. (2008, March 30). Too Many Women Still Dying From Breast Cancer, Says UK Charity. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/03/080327172227.htm
BioMed Central. "Too Many Women Still Dying From Breast Cancer, Says UK Charity." ScienceDaily. www.sciencedaily.com/releases/2008/03/080327172227.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins